Maven Capital Partners (“Maven”) and Albion Ventures LLP (“Albion”), two of the largest independent venture capital investors in the UK, today jointly announce the successful sale of their investment in Lab M Holdings, a developer, manufacturer and supplier of microbiological culture media and diagnostic systems, to Neogen Corporation.

Lancashire-based Lab M is a leading provider of microbial testing and diagnostic products servicing the global food, water, industrial and clinical testing markets.  Employing some 35 staff at its accredited facility in Heywood, Greater Manchester, the company’s widerange of dehydrated culture media is routinely used in microbiology laboratories around the world for food industry testing.  The original Lab M investment was made by Quester VCT Plc and...

Do you love science? We do too at Sartorius!

That’s why we are sharing our #passionforscience with you. Join the global #passionforscience community: Take pictures, participate in our contest, vote for your favorite images and be among the winners of attractive prizes. Share your pictures and videos with your friends on social platforms and add your take to the longest #passionforscience video ever. Visit www.passionforscience.com and get our free #passionforscience app.

AMRA, Bergenbio and Nexstim have been announced as the recipients of the Nordic Stars 2015 Awards.

The awards were presented at the conclusion of the Nordic Life Science Days in Stockholm, which again set a new record for attendance, with over 1000 delegates from 31 countries, establishing itself as the premier Nordic life sciences event. Nordic Stars Awards were introduced in 2013 in special recognition of life science companies in the Nordic region demonstrating outstanding innovation and entrepreneurial skills. "This year's winner of the...

Royal Society of Chemistry, London, 24 November 2015, 2.30pm onwards

D Young & Co, the leading intellectual property law firm, today announced details of its seminar: ‘Bridging the Gap Between Academia and Industry in Life Sciences’. The seminar will take place from 2.30pm on 24^th November at the RSC in London. Attendance is free of charge, and interest can be registered by emailing registrations@dyoung.com. Tailored for small to medium innovative life science companies and universities, including technology...

Chromatography is a versatile analytical technique used to separate a mixture into its individual components.

New international cGMP & cGDP certification for pharmaceutical excipients, growing food safety concerns, increased importance of chromatography tests in drug approvals, and incessant new product launches are major factors driving this market. In addition, the chromatography instruments market has witnessed various technological advancements to meet the needs of biotechnology and biopharmaceutical companies; food and beverage, chemical...

Now available to clinical laboratories in Europe for general in vitro diagnostic use

Thermo Fisher Scientific, the world leader in serving science, today announced that it received the in vitro diagnostics device (IVDD) CE mark for its Thermo Scientific Prelude MD HPLC, Endura MD mass spectrometer and ClinQuan MD software. Available for general in vitro diagnostic use in Europe, clinical laboratories now have access to a high performance liquid chromatograph, mass spectrometer and LC-MS software designed and manufactured for in...

Horizon to exclusively out-license existing human diploid and haploid cell line collection for use in validating the function of Abcam antibodies

• Horizon to receive exclusivity payments totaling £660,000 (c$1,000,000) across an initial three year term with a further potential £1,275,000 (c$1,950,000) across years four to six if Abcam extends the exclusive period
• Horizon to develop additional haploid cell lines on demand under a preferred pricing arrangement
• Horizon to receive a royalty on the sale of Abcam antibodies marketed using validation data derived from Horizon cell lines

From the 1^st to the 4^th September, a delegation of Medical Technology firms from The Netherlands visited the UK to learn about the healthcare sector and share their innovative products and systems.

The main goal of the trade mission was to enable participating companies to gain insight in the workings of the NHS, to find new British partners and distributors; and establish new partnerships by discussing directly with NHS officials and UK companies what the Netherlands can offer in terms of technology and high-quality equipment in health care. During the 4 day visit, the delegates participated in a full day at Citylabs in Manchester to learn about...

Quotient Clinical, the Translational Pharmaceutics^® company, has expanded its data sciences services in response to increasing customer demand, doubling the footprint of its facilities in Edinburgh and Nottingham, as well as increasing its specialist headcount and appointing a new Vice President.

Data sciences is an integral part of the company’s service, delivering real-time data to customers for review and interpretation, enabling crucial dosing decisions to be made during the course of a study. Greg Johnson, the new Vice President of Data Sciences, joined Quotient in March 2015 and has over 25 years’ industry experience of directing biometrics and data sciences in large contract research organizations. Mark Egerton, CEO of Quotient Clinical said...

A copper-lined incubator has been installed in the University of Liverpool’s Biological Sciences Department to help reduce the spread of bacteria associated with life science laboratory contamination.

Copper is a powerful antimicrobial with rapid, broad-spectrum efficacy against bacteria and viruses, including MRSA, E.coli and norovirus.  It shares this benefit with a range of copper alloys – such as brasses and bronzes – forming a family of materials collectively called ‘antimicrobial copper’. John Jerger of Triple Red UK, who supplied and installed the NuAire incubator, explains: ‘Bacterial contamination was a particular concern for this client, so we supplied...

Phenomenex, Inc. and the Tecan Group (SIX Swiss Exchange: TECN) today announced a collaboration to co-market automated solid phase extraction (SPE) sample preparation solutions.

The two companies will jointly market Phenomenex Strata™ and Strata-X SPE sorbents adapted to Tecan’s Freedom EVO^® series of robotics workstations. The solution is especially geared to high-throughput customers in pharmaceutical research, clinical and food testing environments using mass spectrometry detection methods. As part of the global agreement, Tecan will provide the instruments and automation support, and Phenomenex will provide the extraction...

Microsaic Miniaturised Mass Spectrometry Instruments Now Compatible with the Clarity Chromatography Control Platform

Microsaic Systems plc (AIM: MSYS), the high technology company developing the next generation of miniaturised mass spectrometry (MS) instruments, is pleased to announce that its  product range is now compatible with Clarity Chromatography Software, the advanced Chromatography Data Station developed by Data Apex.

Horizon Discovery Group plc, the international life science company supplying research tools and services that power genomics research and the development of personalised medicines, and Redx Pharma plc, today announce a research collaboration to progress Redx’s novel pan-RAF inhibitor program, for out-licensing in oncology indications including colorectal cancer, the fourth most common cancer and the second most common cause of cancer death in the UK.

Redx’s pan-RAF inhibitor program has identified next generation novel small molecule inhibitors of RAF kinases as potential treatments for colorectal and other potential cancers. These next generation pan-RAF inhibitors have been designed to overcome resistance mechanisms seen with first generation RAF inhibitors in colorectal cancer. As part of the collaboration, Horizon will deploy its proprietary gene editing, cell line and drug discovery...

MedCity and Design Council have today launched a competition to win a ten-week accelerator coaching course for medtech entrepreneurs to develop effective, usable and commercially successful health technologies that can support older people or those with debilitating medical conditions to lead more independent lives.

The MedTechSouthEast programme, supported by AXA PPP healthcare, gives south-east based individuals and teams with a technology at proof of concept stage a chance to compete for one of ten places on the intensive coaching course, which will be led by design experts and medical technology industry leaders. The ten finalists will also be automatically entered into the AXA PPP Health Tech & You Awards 2016, an initiative that aims to recognise...

Link Technologies appoints Swiss company as first partner in Europe

LINK the innovative developer and manufacturer of nucleic acid reagents, has announced the appointment of a new distributor in Switzerland - Chemie Brunschwig AG. This is LINK’s first formal partnership in Europe, and an important part of its strategy to strengthen Company representation in important market segments, thus increasing access to LINK’s range of innovative reagents for oligo therapeutics and diagnostics. Chemie Brunschwig AG distributes...

New analysis from Frost & Sullivan, Analysis of the Global Flow Cytometry Market, finds the market earned revenues of $2.50 billion in 2014 and estimates this to reach $3.52 billion in 2018 at a compound annual growth rate of 8.9 percent. 

For complimentary access to more information on this research, please visit:Revenues from reagents for clinical applications will be greater than the profits from research-use-only reagents. This is because the demand for in vitro diagnostic kits is high for several clinical applications, such as the analysis of leukemia and lymphoma, enumeration of stem cells, diagnosis of HIVinfection and immunodeficiency diseases, as well as quality control...

Market leaders in temperature controlled microscopy, Linkam Scientific Instruments, are pleased to announce a new member of staff to join their growing sales and marketing support team.

Linkam's continued growth in sales worldwide has led to a further hire in the support team under sales and marketing manager, Duncan Stacey. He outlines the position: “With our sales and product development being driven by feedback from our users a Market leaders in temperature controlled microscopy, Linkam Scientific Instruments, are pleased to announce a new member of staff to join their growing sales and marketing support team. Linkam's continued...

Concept Life Sciences, scientific Laboratory and consultancy group has acquired CXR Biosciences.

This marks its fourth acquisition since it was formed in July 2014. Led by Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan the Concept Life Sciences Group currently has over 600 staff in 11 core locations, with advanced plans for further expansion into continental Europe. CXR Biosciences is a leading investigative toxicology business. Its in-house expertise assists international life sciences companies to resolve issues relating to...

Markus Lusser is the new President and Director of Leica Microsystems, headquartered in Wetzlar, Germany.

This appointment became effective July 1, 2015. He succeeds Andries Peter Jan van den Broek who has left the company.  Before joining Leica Microsystems, Markus Lusser was Vice President Global Sales and Customer Support with Sciex. Sciex produces analysis instruments and, like Leica Microsystems, belongs to the U.S. company, Danaher Corporation. Lusser holds an Electrical Engineering Degree in Telecommunications and Electronics from...

Unique System Proven to Improve Laboratory Workflow and Productivity for Infectious Disease

Beckman Coulter Diagnostics is showcasing its DxN VERIS Molecular Diagnostics System* at the European Society for Clinical Virology (ESCV) meeting in Edinburgh, Scotland, 9-12 September 2015 on booth G5 where delegates can learn more about this new instrument that is set to revolutionise laboratory workflow. Recent evaluations undertaken in the UK and Spain have shown that DxN VERIS is simple to use (routine operator training taking approximately...

Antibiotic Research UK will announce at its Annual General meeting today its first research programme to tackle antibiotic resistant bacteria (superbugs).

Superbugs are becoming an increasing problem in hospitals as bacteria become more and more resistant to our existing antibiotics. The Chief Medical Officer, Dame Sally Davies recently said that if we don’t tackle the problem now our grandchildren will not thank us. All the medical procedures we currently take for granted such as cancer treatment, open heart surgery, hip and knee replacement and organ transplantation will become much more...